Dividend
-
-
-
-
-
-
-
Catalyst Biosciences Reports Third Quarter Operating & Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

